|
" Endocrine Therapies in Breast and Prostate Cancer "
edited by C. Kent Osborne.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
726460
|
| Doc. No
|
:
|
b546192
|
| Main Entry
|
:
|
edited by C. Kent Osborne.
|
| Title & Author
|
:
|
Endocrine Therapies in Breast and Prostate Cancer\ edited by C. Kent Osborne.
|
| Publication Statement
|
:
|
Boston, MA: Springer US, 1988
|
| Series Statement
|
:
|
Cancer treatment and research, 39.
|
| Page. NO
|
:
|
(180 pages).
|
| ISBN
|
:
|
1461317312
|
|
|
:
|
: 9781461317319
|
| Contents
|
:
|
1. Preclinical Studies and Antitumor Mechanism of Action of Luteinizing Hormone-Releasing Hormone Analogues --;2. Luteinizing Hormone-Releasing Hormone Analogues in the Treatment of Prostate Cancer --;3. Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Breast Cancer --;4. Aromatase Inhibitors as New Endocrine Therapy for Breast Cancer --;5. Clinical Use of Aromatase Inhibitors in the Treatment of Breast Cancer --;6. Aminoglutethimide: Theoretical Considerations and Clinical Results in Advanced Prostate Cancer --;7. Antiestrogen Therapy for Breast Cancer: Current Strategies and Future Prospects --;8. Effects of Estrogens and Antiestrogens on Cell Proliferation: Implications for the Treatment of Breast Cancer --;9. Flutamide and Other Antiandrogens in the Treatment of Advanced Prostatic Carcinoma --;10. Progestational Agents in the Treatment of Breast Cancer.
|
| Abstract
|
:
|
The clinical role for other new treatments has not yet been clearly defined, although exciting preliminary data from recent clinical trials are now available. ' Chapters 4, 5, and 6 review the rationale and clinical use of the compounds known collec- tively as the aromatase inhibitors, which can also be used to suppress sex steroid hormone levels.
|
| Subject
|
:
|
Medicine.
|
| Subject
|
:
|
Oncology.
|
| LC Classification
|
:
|
RC280.B8E358 1988
|
| Added Entry
|
:
|
C Kent Osborne
|
| |